Charles F McTiernan

Title: Innovations of Charles F McTiernan

Introduction

Charles F McTiernan is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of medical technology, particularly in the area of nucleic acid delivery systems. With a total of 4 patents to his name, McTiernan's work is paving the way for advancements in therapeutic applications.

Latest Patents

One of McTiernan's latest patents is the "Microbubble nucleic acid delivery platform." This invention pertains to a lipid-based microbubble that stably binds a plurality of nucleic acids. It also includes a method for delivering the microbubble and nucleic acids to a specific target site using ultrasound. The delivered nucleic acids create transgenic cells, such as transgenic tumor cells, which express the proteins encoded by the delivered nucleic acids. This technology significantly improves microbubble-drug delivery platforms, as known microbubbles do not efficiently bind nucleic acids. The improvements include identifying proper lipid proportionality ratios and cationic surfactant layers that provide an optimum mechanical index compatible with ultrasonics. The system allows for microbubble perfusion and nucleic acid delivery through a combination of imaging and ultrasound/microbubble targeted delivery, enabling low power two-dimensional imaging and high power microbubble destruction. Such systems are beneficial in therapeutics and diagnostics, as demonstrated by the proof of principle in delivering therapeutic siRNA molecules to slow tumor growth.

Career Highlights

Charles F McTiernan is affiliated with the University of Pittsburgh, where he continues to innovate and contribute to research in medical technology. His work has garnered attention for its potential applications in improving treatment methods for various diseases.

Collaborations

Some of McTiernan's notable coworkers include Flordeliza Villanueva and Andrew Carson. Their collaborative efforts contribute to the advancement of research and development in their respective fields.

Conclusion

Charles F McTiernan's innovative work in nucleic acid delivery systems exemplifies the potential of medical technology to transform therapeutic practices. His contributions are paving the way for future advancements in the field.